课题基金 / 基金详情

Core--Biochemistry

Core--Biochemistry
核心--生物化学
批准号:
7218015
负责人:
Kathleen Bridget Brosnihan
金额:
$15.32万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2009-03-31

项目摘要

项目成果

Kathleen Bridget Brosnihan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Biochemistry Core Laboratory provides analytical support for the individual projects described in this Program grant application. The majority of the analytes required by the investigations described here are measured by radioimmunoassay (RIA), enzyme immunoassay (EIA), and enzymatic assays. By having all the samples generated by individual investigators analyzed by staff with long experience with RIA, EIA, and enzymatic techniques, in laboratories equipped with suitable instruments, data can be obtained in a more uniform manner, with the strictest possible quality control and minimum of reagent expense. Samples from several investigators can be analyzed within one assay run, thus preventing the wastage which would be incurred by separate investigators analyzing small numbers of samples. Additionally, work can be scheduled more efficiently so that the technologists' time is utilized with maximum efficiency resulting in almost no slack time. The projects of several investigators are worked on at the same time, thus reducing reagent costs, waste of labor and providing more uniform results. The role of the Biochemistry Core Laboratory is to provide analytical support to the investigators in this application by processing and analyzing the samples generated by the various projects, maintain quality control and proficiency, and reduce reagent and personnel expense. By centralizing the performance of sample processing and analysis, the laboratory can assist each investigator with the proper collection techniques, sample size and other pre-analytic factors that may influence the success of a given analysis. Quality control, technical proficiency, and equipment performance can be easily monitored to assure the accuracy of results. Therefore, personnel and reagents can be utilized more efficiently while maintaining the quality of the analyses. The centralized core helps evaluate and implement new technologies and equipment which influence the results of this project. The Core's development of the Nova 1(TM) Electrolyte Analyzer and the Luminex (TM) Protein Multiple Immunoassay helps increase efficiency and productivity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VisualSonics Vevo LAZR Photoacoustic Imaging System
ACE2 Deficiency: A new model of maternal and fetal growth restriction.
ACE2 Deficiency: A new model of maternal and fetal growth restriction.
ANG-(1-7) AND PROSTANOIDS IN NORMOTENSIVE AND HYPERTENSIVE PREGNANCY
海外基金